// App-Quantinova.ai

EP976 : SURVIVAL AMONG OLDER PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA TREATED WITH SELINEXOR, BORTEZOMIB, AND DEXAMETHASONE (XVD) IN THE BOSTON STUDY

Researchers

Presenter

  • Thierry Facon

Principal Investigators

  • Maria Gavriatopoulou

  • Sosana Delimpasi

  • Maryana Simonova

  • Ivan Spicka

  • Ludek Pour

  • Meletios Dimopoulos

  • Iryna Kriachok

  • Halyna Pylypenko

  • Xavier Leleu

  • Hang Quach

  • Reuben Benjamin

  • Tuphan Kanti Dolai

  • Dinesh Kumar Sinha

  • Mamta Garg

  • Don Ambrose Stevens

  • Jatin Shah

  • Paul Richardson

  • Sebastian Grosicki

Medical Centers

  • CHU Poitiers - Hopital La Miletrie, Poitiers, France

  • Zespól Szpitałi Miejskich w Chorzowie, Chorzów,Chorzów,Poland

  • King's College Hosptial NHS Foundation Trust, London, United Kingdom

  • University Hospital of Lille, Lille, France

  • Institute of Blood Pathology &amp

  • General Hospital Evangelismos, Athens, Greece

  • Dana-Farber Cancer Institute, Boston, MA, United States

  • Nil Ratan Sircar Medical College and Hospital, Kolkata, India

  • National Cancer Institute MPH of Ukraine,Kiev,Ukraine

  • 'Cherkasy Regional Oncology Dispensary' of Cherkasy Regional Council, Regional Treatment and Diagnostic Hematology Center,Cherkasy,Ukraine

  • School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

  • University Hospital Brno, Brno, Czech Republic

  • University Hospitals Leicester NHS Trust, Leicester, United Kingdom

  • State Cancer Institute, Indira Gandhi Institute of Medical Sciences,Patna,India

  • Karyopharm Therapeutics Newton MA United States

  • Norton Cancer Institute, St. Matthews Campus,Louisville,United States

  • Prague General University Hospital, Prague, Czech Republic

  • National and Kapodistrian University of Athens, Athens, Greece

  • NCRI and Imperial College London, London, United Kingdom

  • Transfusion Medicine of National Academy of Medical Sciences of Ukraine,Lviv,Ukraine

  • St Vincents Hospital, University of Melbourne, Melbourne, Victoria, Australia

Locations

  • France

  • Poland

  • United Kingdom

  • Greece

  • United States

  • India

  • Ukraine

  • Czech Republic

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Bortezomib

  • Selinexor

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Controlled

Phase

  • III

Study Id's

  • NCT03110562

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved